Will North Carolina’s employment in Pharmaceutical and Medicine Manufacturing for December 2026 be above 26,500 jobs?

- [2026-10-18] The BLS series page (SMU37000003232540001) was pulled today. The latest value is August 2026 at 26.4 (preliminary). 2026 so far, in thousands: Jan 26.3, Feb 26.2, Mar 26.3, Apr 26.3, May 26.2, Jun 26.3, Jul 26.4, Aug 26.4(P). https://data.bls.gov/timeseries/SMU37000003232540001 - [2026-10-18] The same page shows 2025 values: Jan 26.4, Feb 26.4, Mar 26.7, Apr 26.4, May 26.5, Jun 26.6, Jul 26.2, Aug 26.5, Sep 26.4, Oct 26.5, Nov 26.4, Dec 26.5. December 2025 is exactly 26.5, so the threshold equals last year's December value. "Above 26,500" needs a December 2026 print of 26.6 or more, because the series is reported to one decimal. https://data.bls.gov/timeseries/SMU37000003232540001 - [2026-10-18] Year-over-year, the 2026 values run 0.0 to 0.3 below the matching 2025 months. The exception is July 2026 at 26.4, which is 0.2 above July 2025 at 26.2. The series peaked at 27.0 in March 2024 and has moved sideways between about 26.2 and 26.7 since then. https://data.bls.gov/timeseries/SMU37000003232540001 - [2026-10-18] Seasonal pattern: December was above November in 2019, 2020, 2021, 2022, 2023 and 2024, and equal to November in 2025 (26.4 to 26.5, an increase of 0.1). September to December changes were: 2023 +0.4, 2024 −0.1, 2025 +0.1. This is computed from the series table. https://data.bls.gov/timeseries/SMU37000003232540001 - [2026-09-18] NC Commerce released the August 2026 state data. NC total nonfarm employment was up 10,000 over the month. Manufacturing was up 200 over the month seasonally adjusted, but down 8,900 over the year. https://www.commerce.nc.gov/news/press-releases/2026/09/18/north-carolinas-august-employment-figures-released - [2026-06-23] NC Commerce LEAD said NC manufacturing ended 2025 with 3,600 fewer jobs than a year earlier, the third straight annual decline. It projects almost no net manufacturing job growth over 2024–2034. https://www.commerce.nc.gov/news/the-lead-feed/june-2026-nc-economy-watch - [2026-10-02] The national jobs report for September 2026 showed payrolls up 29,000 and unemployment at 4.2%, with little change in major industries. National chemical manufacturing employment (seasonally adjusted) was 905.5 thousand in September (preliminary), up from 901.4 in June. https://www.bls.gov/news.release/empsit.nr0.htm and https://www.bls.gov/iag/tgs/iag325.htm - [2026-10-18] BLS schedule: state data for September 2026 has no date on the schedule page, which lists only the October release (2026-11-20) and the November release (2026-12-18). The national December 2026 jobs report is due 2027-01-08. https://www.bls.gov/schedule/news_release/laus.htm and https://www.bls.gov/schedule/news_release/empsit.htm - [2026-10-18] The December 2026 state value will first appear as preliminary, probably in a state release in January or February 2027. I did not find the exact date. The annual benchmark revision normally comes in March, so the "first non-preliminary" value probably arrives with that revision, shortly before the 2027-03-31 close. The February 2026 BLS schedule delay for January and February data shows that release dates can shift. https://esd.wa.gov/about-us/news-release/2026/advisory-bls-announces-labor-market-and-employment-information-release-schedule - [2026-10-18] September 2026 NC data is not yet published. Page extracts show the September 2026 national report was released on schedule (2026-10-02), so there is no sign of a data blackout. I did not verify the status of the state release. https://www.bls.gov/news.release/empsit.nr0.htm - [2026-09 / 2026-06] NC pharma investment is large (Novo Nordisk, Fujifilm Diosynth, Amgen, about $15B), but the BLS series has not shown a lift. Jobs from new plants may show up later. https://manufacturingamerica.org/states/manufacturing-north-carolina BOTTOM LINE: The latest print is 26.4 (August 2026, preliminary), and the series has been flat at 26.2–26.4 all year. Reaching 26.6 or more in December would need a rise of 0.2 or more over the August print. Last year's Q4 seasonal lift was small (September 26.4 to December 26.5), and a benchmark revision in March 2027 could also move the level. NOT FOUND: the BLS release dates for state data for December 2026 and the March 2027 benchmark; the September 2026 NC pharma value; any NC pharma-specific layoffs or hiring news from the last 14 days.

- [2026-10-18] The series is SMU37000003232540001, NC pharma and medicine manufacturing, not seasonally adjusted, in thousands. The BLS API shows Aug 2026 at 26.4 (preliminary) and Jul 2026 at 26.4. Earlier 2026 months: Jan 26.3, Feb 26.2, Mar 26.3, Apr 26.3, May 26.2, Jun 26.3. Dec 2025 is 26.5. "Above 26,500" needs a published value of at least 26.6, because the series is reported to one decimal. https://api.bls.gov/publicAPI/v2/timeseries/data/SMU37000003232540001?startyear=2023&endyear=2026 - [2026-10-18] Historical Decembers: 2023 was 26.7, 2024 was 26.5, 2025 was 26.5. Over the last 12 months (Sep 2025 to Aug 2026) the values ranged 26.2 to 26.5, and none reached 26.6. The last time the series was at or above 26.6 was Sep 2024 (26.6) and earlier. Only 2 of the 7 months from Mar 2025 to Sep 2025 reached 26.6 or higher: Mar 2025 at 26.7 and Jun 2025 at 26.6. https://api.bls.gov/publicAPI/v2/timeseries/data/SMU37000003232540001?startyear=2023&endyear=2026 - [2026-10-18] Month-to-month noise is typically ±0.1 to 0.3 (for example Jun 2025 26.6, Jul 2025 26.2, Aug 2025 26.5). Year-over-year change from Aug 2025 to Aug 2026 is -0.1. The 2026 trend is flat to slightly down, 0.1 to 0.2 below the Dec 2025 level of 26.5. This is not a firm uptrend. https://api.bls.gov/publicAPI/v2/timeseries/data/SMU37000003232540001?startyear=2023&endyear=2026 - [2026-09-18] NC total manufacturing is weak. Jobs fell 8,900 year over year to Aug 2026, though they rose 200 over the month. The NC Commerce release is the source. https://www.commerce.nc.gov/news/press-releases/2026/09/18/north-carolinas-august-employment-figures-released - [2026-10-18] Release timing: Sep 2026 state data comes out 2026-10-20, Oct on 11-20 and Nov on 12-18. The Dec 2026 state data should come in late Jan 2027 (the Dec 2025 data came out 2026-01-27). The last two BLS pages I fetched do not show the Jan 2027 date. https://www.bls.gov/schedule/news_release/laus.htm - [2026-08-28] The final annual benchmark is due in March 2027 with the January 2027 state release. It revises NSA data from Apr 2025 to Dec 2026. The "first non-preliminary" Dec 2026 value is therefore probably the benchmarked March 2027 figure, which falls before the 2027-03-31 close. A benchmark shift of ±0.1 to 0.3 could move the value across the threshold. The average absolute state-total revision for March 2026 was 0.4%. https://www.bls.gov/news.release/archives/presae_08282026.htm - [2026-01-20] Pipeline of NC pharma capacity: Genentech Holly Springs (about 500 jobs, operational by end of 2029), Novo Nordisk Clayton (1,000 jobs), Amgen Holly Springs (370 jobs) and J&J Wilson (420 jobs). Most of these come online after Dec 2026, so near-term uplift is limited, though construction-phase hiring could add a few hundred jobs. https://www.wral.com/business/genentech-expansion-holly-springs-feb-2026/ - [2026-08] BioSpace reports NC biopharma job postings up 26% year over year in July 2026. This is a soft leading indicator and has not yet shown up in the BLS series. https://www.biospace.com/job-trends/7-companies-hiring-in-north-carolina-now-0826 - [2026-10-18] The base rate for a ≥26.6 print: of the last 12 months, 0 of 12 were ≥26.6. Of the last 24 months, roughly 7 of 24 were ≥26.6 (Jan to Sep 2024 mostly, plus Mar and Jun 2025). The Aug 2026 gap to the threshold is +0.2. https://api.bls.gov/publicAPI/v2/timeseries/data/SMU37000003232540001?startyear=2023&endyear=2026 BOTTOM LINE: The series has sat at 26.2–26.4 all of 2026 and has not printed 26.6 or higher in the past 12 months, so the outside view leans No. A rise of at least +0.2 by December, or a favourable March 2027 benchmark revision, would be needed, and that is plausible given the series' ±0.1–0.3 noise and the revision risk. NOT FOUND: Any published forecast, expert estimate or other-venue market for this series. The Sep 2026 value, which is due 2026-10-20. The exact Jan 2027 release date for Dec 2026 state data. Pre-benchmark revision size for this specific series.

YES means: BLS series SMU37000003232540001 (NC pharmaceutical and medicine manufacturing, NSA) shows a first non-preliminary December 2026 value of 26.6 thousand or higher. The series is published to one decimal, so a value of 26.5 resolves No. - [2026-08-28] The final benchmark for state series is due in March 2027 with the January 2027 state release. It revises all NSA data from April 2025 to December 2026. Two things follow. - The "first non-preliminary" December 2026 value is therefore the benchmarked March figure, not the sample-based January print. The benchmark can move the whole 2025–26 level, so the flat 26.2–26.4 sample-based path in 2026 is not binding. - The state benchmark is a QCEW-based level reset. Pharma plants ramping up (see the Fujifilm bullet below) are the kind of expansion that UI-tax records capture and the sample can miss. - Source: https://www.bls.gov/news.release/archives/presae_08282026.htm - [2026-08-28] The average absolute preliminary state-total benchmark revision was 0.4%. Revisions across states ranged from -1.2% to +1.0%, and 28 states plus DC were revised up. A 0.4% revision on a 26.4 base is about 0.1, so a +0.2 shift needs an above-average revision. Nationally, the preliminary benchmark for total nonfarm was only -0.1%, much smaller than the prior two years. I did not find an NC-specific or pharma-specific preliminary revision. Source: https://www.bls.gov/news.release/archives/presae_08282026.htm - [2026-09-18] BLS reported NC nonfarm employment at 5,128,400 in August 2026, up 65,600 (1.3%) over the year. That was the third-largest gain among states. NC's overall labor market is expanding, which is a backdrop for life-science hiring even though manufacturing as a whole is shrinking. Source: https://www.bls.gov/news.release/laus.nr0.htm - [2026-09-24, dated by the "384 days ago" age shown on the search result] Fujifilm Holly Springs opened in September 2025 with over 680 staff. It was on track for 750 by the end of 2025 and has a target of 1,400 by 2031. That is roughly 100+ net additions a year from one site, about 0.4% of the series level. Hiring there is gradual, so this alone is not enough for +0.2. Source: https://fujifilmbiotechnologies.fujifilm.com/about/news/opening-of-commercial-scale-cell-culture-manufacturing-site-in-north-carolina/ - [2024-06-24] Novo Nordisk's Clayton facility was announced with 1,000 hires. Axios said it "should open in 2027", and Novo already employed nearly 2,500 in Durham and Clayton. Pre-opening hiring and training in late 2026 is the most plausible source of a step up. Whether those hires are coded to NAICS 3254 or to construction is not confirmed. Source: https://www.axios.com/local/raleigh/2024/06/24/ozempic-maker-novo-nordisk-triangle-north-carolina-expansion - [2026-10] Glassdoor lists 1,073 open pharmaceutical manufacturing jobs in NC and 543 in the Research Triangle Park area, including Novartis Morrisville manufacturing leads and technician roles in Wilson. Indeed shows about 1,000. This is demand evidence only; it does not show net hiring. Sources: https://www.glassdoor.com/Job/north-carolina-pharmaceutical-manufacturing-jobs-SRCH_IL.0,14_IS1282_KO15,43_IP3.htm and https://www.indeed.com/jobs?l=North+Carolina&q=Pharmaceutical+Manufacturing&redirected=1 - [2026-10-02] Nationally, the September 2026 payroll report showed little change in major industries. The earlier national chemical-manufacturing rise already noted (901.4 to 905.5) shows the broader sector is not shrinking. Source: https://www.bls.gov/news.release/empsit.nr0.htm - [2026-10-18] The release schedule matters for the path. The September 2026 state data is due 2026-10-20, and BLS confirms the date. One more month of data will therefore be visible within days. A September print of 26.5 or higher would put the series within 0.1 of the threshold. Source: https://www.bls.gov/news.release/pdf/laus.pdf - [2026-07-16] Fujifilm Holly Springs staff report a shift from "project phase" to "operational phase" with morale problems, and one employee reviewer in May 2026 mentioned that "layoffs hit" earlier. This is a Yes headwind, not support. I found no confirmed NC pharma layoffs in the last 30 days. Source: https://www.indeed.com/cmp/Fujifilm-Diosynth-Biotechnologies/reviews BOTTOM LINE: The most likely path to YES is a combination of two things. One is a seasonal and ramp-up lift into December (Novo Clayton pre-opening hires, Fujifilm additions, and a December value that has been at or above November in 7 straight years). The other is a favorable March 2027 QCEW benchmark that lifts the level by at least 0.2. The evidence I found is supportive but not decisive. It rests on investment and hiring demand rather than on any BLS print of 26.6 or higher in the past 12 months. NOT FOUND: the NC-specific or pharma-specific preliminary benchmark revision; the September 2026 NC pharma value (due 2026-10-20); the exact date of the January 2027 state release; confirmed NC pharma net-hiring figures from QCEW or NC Commerce for 2026.

YES means: BLS reports North Carolina Pharmaceutical and Medicine Manufacturing employment (SMU37000003232540001, not seasonally adjusted) for December 2026 at 26.6 thousand or higher. The first non-preliminary value is the one that counts. - [2026-10-18] Status quo favours NO. The series has not printed 26.6 or more in any 2026 month, and it sits 0.2 below the threshold at the last print (Aug 2026, 26.4). Because the threshold equals the Dec 2025 print, a flat or slightly lower December also resolves NO. Only a net gain of at least 0.2 resolves YES. Source: https://data.bls.gov/timeseries/SMU37000003232540001 (from the colleagues' pull, which I did not re-fetch). - [2026-10-02] National manufacturing is not providing a tailwind. The national data showed employment in all major industries changing little in September, with payrolls up only 29,000. Downward revisions to July and August totalled 60,000, per a 2026-10 opinion column. Sources: https://www.bls.gov/news.release/empsit.nr0.htm and https://www.wakeweekly.com/columns/opinion-ncs-economy-looks-more-resilient-than-the-nations-8175b9b2 - [2026-02-27] The Merck Durham Gardasil wind-down is a specific headwind that new capacity has not offset. Merck filed WARN notices for 147 workers plus 7 others, effective 2026-05-01, because of falling worldwide demand. That is roughly 0.6% of the series level, and it falls inside the 2026 period when the series ran below 2025 levels. Sources: https://www.fiercepharma.com/manufacturing/merck-lay-nearly-150-staffers-research-triangle-area-vaccine-plant and https://www.layofflookout.com/warn-notices/north-carolina - [2025-10-07] Novo Nordisk cut staff at its Clayton plant after its 9,000-job global reduction. Reuters found 47 LinkedIn posts from laid-off workers. Novo's 1,000-job expansion has a first phase scheduled for 2027, so it does not arrive by December 2026. Source: https://www.drugdiscoverytrends.com/novo-nordisk-lays-off-dozens-of-us-employees-at-nc-plant/ - [2026-10-07] Layoffs continue across the industry. The Fierce Biotech tracker lists a further EMD Serono Durham research cut (Jan 13). Xtalks lists TScan (Sept 2026), which is winding down internal manufacturing, though not located in NC. Most of these are R&D or biotech firms rather than manufacturing, so the effect on this series is only indirect. Sources: https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2026 and https://xtalks.com/pharma-and-biotech-layoffs-2026-watch-4631/ - [2026-Q2] NC total manufacturing was down 11,200 year over year in Q2 2026, after down 12,200 in Q1. Statewide manufacturing is still shrinking even though August showed +200 month on month. The pharma sub-series is a small component of that total. Sources: https://dmjps.com/north-carolina-economic-report-2026-second-quarter/ and https://dmjps.com/north-carolina-economic-report-2026-first-quarter/ - [2026-08-28] On the benchmark, BLS's own wording confirms that the final benchmark arrives with the January 2027 state release in March 2027. It revises NSA data from April 2025 to December 2026. The March 2026 average absolute preliminary revision across states was 0.4%, smaller than the 0.7% in 2025. A 0.4% move on 26.4 is about 0.1, so a benchmark shift alone is unlikely to be decisive. The direction for NC pharma is unknown. One source gives February 2027 for the final revisions, a conflict I could not settle; either date is before the 2027-03-31 close. Sources: https://www.bls.gov/news.release/archives/presae_08282026.htm and https://www.americanactionforum.org/daily-dish/revisions-published-with-thankfully-little-fanfare/ - [2026-09-04] The Philadelphia Fed early benchmark found 19 states with significant differences versus preliminary CES for Sept 2025 to March 2026, mostly lower changes (14 states lower versus 5 higher). The Philly Fed table in the PDF did not give NC's figure in my fetch. The skew toward downward revisions mildly favours NO. The next vintage is due 2026-12-11. Source: https://www.philadelphiafed.org/-/media/FRBP/Assets/Surveys-And-Data/benchmark-revisions/2026/early-benchmark-2026-q1-report.pdf?sc_lang=en - [2026-10-18] Resolution technicalities that favour NO. Rounding to one decimal means exactly 26.5 resolves NO, which is the Dec 2024 and Dec 2025 outcome. The question also depends on a "first non-preliminary" value, and the colleagues' reports and the BLS pages I saw give no firm date for it. A missing or late publication would leave the outcome at the default NO or an ambiguous resolution before the close. BLS has shifted state releases before: the Sept 2025 state release moved from Oct 21 to Dec 11, and the Oct 2025 state release was canceled. Source: https://www.bls.gov/bls/2025-lapse-revised-release-dates.htm - [2026-10-20] The September state data is due 2026-10-20. NC Commerce's August county release says the next update is scheduled for that date. Source: https://www.commerce.nc.gov/supplemental-release-august-2026-county-and-area-employment-numbers/open - [2026-10-18] The BLS national schedule shows the December 2026 jobs report on 2027-01-08 and January 2027 on 2027-02-05. No lapse in appropriations is signalled for the period before the close. Source: https://www.bls.gov/schedule/news_release/empsit.htm BOTTOM LINE: The series is flat at 26.2–26.4 in 2026 with plant-level layoffs (Merck, Novo) and falling NC manufacturing totals. Resolution needs a December print at least 0.2 above August, and exactly 26.5 resolves NO. The new Novo, Genentech and Amgen capacity mostly arrives after December 2026. NOT FOUND: the September 2026 NC pharma value (due 2026-10-20); the exact BLS date for the December 2026 state release; NC's early-benchmark estimate; any NC pharma-specific layoff news in the last 14 days; any pharma-specific NC revision history.